Reblozyl is the first and only therapy to demonstrate superiority compared to an erythropoiesis stimulating agent (ESA) in MDS-related anemia
Centre aims to train surgeons and other healthcare professionals from India and Southeast Asia in robotic-assisted surgery
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
Need to harmonize traditional and modern medicine to combat alarming health problems
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
Subscribe To Our Newsletter & Stay Updated
